摘要
目的探究增强CT扫描在骨巨细胞瘤诊断中的价值。方法随机入组200例溶骨性骨质破坏患者,依据病变情况分为骨巨细胞瘤组(100例)和非骨巨细胞瘤组(100例),分别给予增强对比剂,对比两组病变的增强后CT值及CT值增加值。结果骨巨细胞瘤组增强后CT值为(128.13±26.13),CT值增加值为(83.11±22.91);非骨巨细胞瘤组增强后CT值为(89.62±33.86),CT值增加值为(47.83±30.19);CT值和CT值增加值的组间差异均具有统计学意义(均P<0.05)。结论增强CT扫描后的CT值及CT值增加值在骨巨细胞瘤的临床诊断中可能具有良好的导向价值。
Objective To explore the diagnostic value of contrast-enhanced CT scan in the giant cell tumor of bone （GCT）. Method 200 patients with osteolytic bone destruction were enrolled and grouped as GCT group （n =100） and non-GCT group （n = 100） based on individual medical conditions, and contrast agents were administered in-travenously for comparison of increments of CT value in the contrast-enhanced CT scan between the two groups. Re-sult The CT value of GCT group in contrast-enhanced CT was （128.13 ± 26.13）, which increased （83.11 ± 22.91）;For non-GCT group, the contrast-enhanced CT value was （89.62 ± 33.86）, which increased （47.83 ± 30.19）; Both of the enhanced CT value and its increments were significantly different between the two groups （all P 〈 0.05）. Conclu-sion After contrast-enhanced CT scan, the CT values and increments may contribute as the guide for clinical diagno-sis of GCT.
出处
《癌症进展》
2015年第3期335-337,共3页
Oncology Progress
关键词
骨巨细胞瘤
增强CT值
CT值增加值
诊断价值
giant cell tumor of bone
enhanced CT value
increment of CT value
diagnostic value
